Kayoko Hayakawa Selected Research

Daptomycin

4/2016	Emergence of a daptomycin-non-susceptible Enterococcus faecium strain that encodes mutations in DNA repair genes after high-dose daptomycin therapy.
7/2014	Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.
1/2014	Daptomycin-induced pneumonitis in a patient with chronic obstructive pulmonary disease (COPD).
12/2012	Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kayoko Hayakawa Research Topics

Disease

28	Infections 12/2023 - 09/2011
22	COVID-19 04/2024 - 06/2020
8	Bacteremia 10/2023 - 05/2012
6	Sepsis (Septicemia) 08/2021 - 04/2012
5	Urinary Tract Infections (Urinary Tract Infection) 10/2023 - 08/2013
4	Malaria 05/2023 - 03/2014
4	Fever (Fevers) 12/2020 - 03/2015
3	Dengue (Dengue Fever) 05/2023 - 03/2014
3	Critical Illness (Critically Ill) 01/2023 - 06/2015
3	Pneumonia (Pneumonitis) 01/2021 - 01/2014
2	Hemorrhage 02/2024 - 08/2022
2	Parasitemia 05/2023 - 11/2014
2	Abscess 05/2023 - 05/2022
2	Thrombosis (Thrombus) 08/2022 - 11/2021
2	Candidemia 01/2019 - 01/2016
2	Typhoid Fever (Typhoid) 01/2016 - 07/2014
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 06/2015 - 01/2013
2	Body Weight (Weight, Body) 06/2015 - 07/2014
2	Wounds and Injuries (Trauma) 12/2013 - 09/2013
1	Hypotension (Low Blood Pressure) 04/2024
1	Disease Progression 12/2023
1	Vomiting 05/2023
1	Falciparum Malaria (Plasmodium falciparum Malaria) 05/2023
1	Anemia 05/2023
1	Fetal Death 05/2023
1	Spontaneous Abortion (Miscarriage) 05/2023
1	Hemolysis 05/2023
1	Osteomyelitis 05/2023
1	Tuberculosis (Tuberculoses) 03/2023
1	Aphasia (Dysphasia) 05/2022
1	Hemiplegia (Spastic Hemiplegia) 05/2022
1	Dyspnea (Shortness of Breath) 03/2022
1	Hypoxia (Hypoxemia) 03/2022

Drug/Important Bio-Agent (IBA)

9	Anti-Bacterial Agents (Antibiotics)IBA 05/2023 - 01/2016
8	Vancomycin FDA LinkGeneric 03/2017 - 05/2012
5	Oxygen (Dioxygen)IBA 04/2024 - 01/2019
5	FluoroquinolonesIBA 01/2021 - 01/2013
4	Carbapenems (Carbapenem Antibiotics)IBA 07/2017 - 04/2012
4	Daptomycin FDA Link 04/2016 - 12/2012
3	Heparin (Liquaemin)FDA LinkGeneric 02/2024 - 06/2020
3	Cefmetazole (Cefmetazole Sodium)FDA Link 10/2023 - 11/2021
3	Immunoglobulin M (IgM)IBA 05/2023 - 03/2016
3	EnzymesIBA 05/2023 - 01/2014
3	Colistin (Coly-Mycin)FDA Link 09/2022 - 12/2012
3	remdesivirIBA 05/2022 - 01/2021
3	beta-Lactamases (beta-Lactamase)IBA 09/2020 - 02/2017
3	Linezolid (Zyvox)FDA Link 07/2014 - 12/2012
3	Cephalosporins (Cephalosporin Antibiotics)IBA 12/2013 - 01/2013
2	Angiotensin Receptor AntagonistsIBA 04/2024 - 10/2022
2	Meropenem (Merrem)FDA LinkGeneric 10/2023 - 04/2012
2	Quinine (Quinson)FDA Link 05/2023 - 01/2018
2	artemisinin (artemisinine)IBA 05/2023 - 11/2014
2	Antimalarials (Antimalarial Agents)IBA 05/2023 - 11/2014
2	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 05/2023 - 11/2014
2	Methicillin (Metin)FDA Link 05/2023 - 09/2013
2	Neutralizing AntibodiesIBA 05/2023 - 02/2017
2	AntibodiesIBA 05/2023 - 08/2015
2	Indicators and Reagents (Reagents)IBA 03/2022 - 08/2021
2	AnticoagulantsIBA 11/2021 - 10/2021
2	CytokinesIBA 01/2021 - 08/2020
2	Inosine Monophosphate (IMP)IBA 01/2021 - 01/2020
2	AminoglycosidesIBA 01/2021 - 12/2013
2	Ampicillin (Omnipen)FDA LinkGeneric 09/2017 - 03/2017
2	Clindamycin (Cleocin)FDA LinkGeneric 09/2017 - 03/2012
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2017 - 01/2016
2	Penicillins (Penicillin)FDA Link 01/2017 - 12/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 03/2015
2	CreatinineIBA 06/2015 - 03/2015
2	C-Reactive ProteinIBA 03/2015 - 03/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2024
1	RNA (Ribonucleic Acid)IBA 12/2023
1	Messenger RNA (mRNA)IBA 12/2023
1	VaccinesIBA 12/2023
1	Dihydrotachysterol (AT 10)IBA 10/2023
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 10/2023
1	ArtesunateIBA 05/2023
1	gluconic acid (gluconate)FDA LinkGeneric 05/2023
1	Hemoglobins (Hemoglobin)IBA 05/2023
1	First Generation CephalosporinsIBA 05/2023
1	Cephalexin (Cefalexin)FDA LinkGeneric 05/2023
1	ImmunosorbentsIBA 05/2023
1	Immunoglobulin G (IgG)IBA 05/2023
1	AerosolsIBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2022
1	favipiravirIBA 06/2022
1	mRNA VaccinesIBA 04/2022
1	flomoxefIBA 03/2022

Therapy/Procedure

16	Therapeutics 10/2023 - 09/2011
5	Drug Therapy (Chemotherapy) 02/2022 - 11/2014
3	Extracorporeal Membrane Oxygenation 04/2024 - 06/2020
2	Cannula 01/2023 - 09/2022
2	Personal Protective Equipment 01/2022 - 01/2021
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 06/2020
2	Catheters 05/2020 - 11/2017
2	Urinary Catheters 01/2019 - 08/2013
1	Mechanical Ventilators (Ventilator) 04/2024
1	Blood Transfusion (Blood Transfusions) 05/2023
1	Synovectomy 03/2023
1	Long-Term Care 04/2022